Nicox【ALCOX】銘柄情報

	リアルタイム株価	レベル2
Forex

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.2145

買値

0.2135

売値

0.2195

出来高

60,663

0.21 日の範囲 0.22

0.14 52 週間の範囲 0.4915

時価総額

10.789M

前日終値

0.22

始値

0.21

時刻

2000

0.2145

最終取引時間

21:58:18

財務取引量

VWAP

平均取引量 (3 か月)

386,366

発行済株式数

50,299,694

配当利回り

PER

-0.51

1 株当たり利益 (EPS)

-0.42

歳入

7.14M

純利益

-20.88M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.nicox.com

本社

Antibes, Alpes-maritimes, Fra

設立

Nicox SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker ALCOX. The last closing price for Nicox was 0.22 €. Over the last year, Nicox shares have traded in a share price range of 0.14 € to 0.4915 €.

Nicox currently has 50,299,694 shares in issue. The market capitalisation of Nicox is 11.07 € million. Nicox has a price to earnings ratio (PE ratio) of -0.51.

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Press Release Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc...

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024 Communiqué de presseNicox : Point financier sur le troisième trimestre 2024 et résultats...

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Topline results from...

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Communiqué de presse Nicox et Soleus signent un...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.005	-2.27790432802	0.2195	0.224	0.206	82148	0.21641815	DE
4	-0.0335	-13.5080645161	0.248	0.2485	0.206	72337	0.22669896	DE
12	0.0409	23.5599078341	0.1736	0.32	0.14	386366	0.26005342	DE
26	-0.1055	-32.96875	0.32	0.325	0.14	262082	0.24290447	DE
52	-0.1825	-45.9697732997	0.397	0.4915	0.14	157612	0.26852404	DE
156	-0.3675	-63.1443298969	0.582	0.65	0.14	133271	0.32183066	DE
260	-0.3675	-63.1443298969	0.582	0.65	0.14	133271	0.32183066	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ALDRVDrone Volt	0.33 € (8,584.21%)	104.21k
ALNEVNeovacs	0.0003 € (50.00%)	38.55M
ALSPWSpineway	0.1355 € (28.19%)	3.92M
TRACTTeract SA	1.045 € (23.23%)	121.87k
ALARFAdeunis	0.896 € (20.75%)	17.22k
ALNMRNamR SA	0.45 € (-17.88%)	2.53k
ALTAILighton	14.90 € (-17.22%)	73.49k
ALEMSEuropean Medical Solutions	0.016 € (-13.04%)	3.14k
ALEUPEuroplasma	0.083 € (-12.63%)	2.13M
OSEOSE Immunotherapeutics	7.78 € (-11.89%)	516.75k
ALNEVNeovacs	0.0003 € (50.00%)	38.55M
ALCYBCybergun	0.0001 € (0.00%)	22.78M
LATLatecoere	0.0087 € (8.75%)	17.7M
BCPBanco Comercial Portugues SA	0.4425 € (-1.18%)	15.49M
ALHPIHopium SA	0.009 € (1.12%)	9.82M